SLC23A1 and COVID-19: Based on their research results and available references, Patterson et al. [179] suggested that, in SARS-CoV-2 infected patients, SVCT1 and SVCT2 AA transporters are downregulated, which might be an essential factor related to the severity of COVID-19.